About this trial
This study focuses on developing an innovative, artificial intelligence-based model using optic nerve sheath ultrasound videos to predict intracranial pressure in lung cancer patients with leptomeningeal metastasis. The study also aims to create a multimodal clinical prognosis model that can help improve patient outcomes. By analyzing ultrasound data from patients at two major medical centres, the research seeks to provide more accurate and early predictions of complications related to elevated intracranial pressure, ultimately improving treatment and management strategies for these patients.
Eligibility criteria
Qualifiers
None
Disqualifiers
1、Histological Type: Patients with squamous cell carcinoma or small cell lung cancer are excluded.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Lead sponsor
Nanjing University
Collaborator
Nanjing Jiangning Hospital
Collaborator